Skip to main content
Top

Supportive Care in Cancer

Issue 5/1999

Content (13 Articles)

EDITORIAL

Cancer in childhood and supportive care

Hans Peter Wagner

SUPPORTIVE CARE INTERNATIONAL

The new Palliative Care Outreach Program – a resounding success

Melanie Hess

SUPPORTIVE CARE NEWS

News from the MASCC Study Groups

REVIEW ARTICLE

Adjustment of siblings to childhood cancer: a literature review

B. A. Houtzager, M. A. Grootenhuis, B. F. Last

ORIGINAL ARTICLE

Observer error in grading performance status in cancer patients

A. E. Taylor, Ian N. Olver, Thileepan Sivanthan, Marianne Chi, Craig Purnell

ORIGINAL ARTICLE

Predictors of physical functioning among geriatric patients with small cell or non-small cell lung cancer 3 months after diagnosis

M. E. Kurtz, J. C. Kurtz, Manfred Stommel, Charles W. Given, Barbara Given

ORIGINAL ARTICLE

Resource implications of febrile neutropenia in cancer patients

Stephan Harbarth, Iris Beeler, Michele Viot, T. D. Szucs

ORIGINAL ARTICLE

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Andreas du Bois, Markus Schlaich, Hans-Joachim Lück, Anne Mollenkopf, Ulrike Wechsel, Matthea Rauchholz, Thomas Bauknecht, Hans-Gerd Meerpohl

ORIGINAL ARTICLE

A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy

Burton Needles, Eduardo Miranda, Francisco M. Garcia Rodriguez, Luis Baez Diaz, Jesse Spector, Johnny Craig, Gary Cohen, Steven Krasnow, J. Brogden, Michael Ames

SHORT COMMUNICATION

Cost–benefit analysis of percutaneous interventional radiological procedures in cancer patients

P. Y. Marcy, P. Chevallier, C. Granon, M. N. Falewee, A. Bleuse, J. N. Bruneton

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine